Another biopharma firm sees insider buying here.
Insiders in the pharma and biotech space continue to be bullish near current prices at many companies. The latest insider buys in the space occurred atNGM Biopharmaceuticals (NGM). Column Group LP, already a major owner with more than a 10 percent stake, bought another 34,000 shares late last week. These buys were shown as going to director Peter Svennilson. Director David Goeddel also picked up shares late last week as well. It’s always refreshing to see large buys by insiders that already have a huge stake in a firm, rather than see...
More







